WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-463 Cr | ₹-559 Cr | ₹-244 Cr | ₹686 Cr | ₹-69 Cr |
What is the latest Consolidated Net Profit of WOCKHARDT ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-463 Cr |
| Mar2024 | ₹-559 Cr |
| Mar2023 | ₹-244 Cr |
| Mar2022 | ₹686 Cr |
| Mar2021 | ₹-69 Cr |
How is Consolidated Net Profit of WOCKHARDT Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-463 Cr | Negative | |
| Mar2024 | ₹-559 Cr | Negative | |
| Mar2023 | ₹-244 Cr | Negative | |
| Mar2022 | ₹686 Cr | Positive | |
| Mar2021 | ₹-69 Cr | - | |
Compare Consolidated Net Profit of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹19,124.6 Cr | -1.8% | -17.8% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -1.8% |
-17.8% |
-8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses